BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/30/2022 3:20:26 PM | Browse: 886 | Download: 1966
Publication Name World Journal of Gastroenterology
Manuscript ID 73525
Country United Kingdom
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Pathology
Manuscript Type Basic Study
Article Title c-MET immunohistochemical expression in sporadic and inflammatory bowel disease associated lesions
Manuscript Source Unsolicited Manuscript
All Author List Grant Halliday, Ross J Porter, Catherine J Black, Mark J Arends and Shahida Din
ORCID
Author(s) ORCID Number
Grant Halliday http://orcid.org/0000-0002-1044-0857
Ross J Porter http://orcid.org/0000-0001-5043-186X
Catherine J Black http://orcid.org/0000-0001-6938-8128
Mark J Arends http://orcid.org/0000-0002-6826-8770
Shahida Din http://orcid.org/0000-0003-2855-3400
Funding Agency and Grant Number
Corresponding Author Shahida Din, BSc, FRCP, MBChB, PhD, Consultant Physician-Scientist, Edinburgh Inflammatory Bowel Disease Unit, Western General Hospital, NHS Lothian, Anne Feguson Building , Edinburgh EH4 2XU, United Kingdom. sdin@exseed.ed.ac.uk
Key Words Inflammatory bowel diseases; Colorectal cancer; Surveillance; Detection; c-MET; Immunohistochemistry
Core Tip During colonoscopy, an intravenous fluorescent anti-c-MET probe may improve endoscopic detection of dysplasia and cancer. However, c-MET expression in inflammatory bowel disease (IBD) lesions is poorly defined, limiting translational studies. We demonstrate that stronger immunohistochemical c-MET expression is associated with dysplasia and cancer in both sporadic and IBD-associated lesions. Therefore, c-MET expression could be exploited clinically to enhance endoscopic detection of pre-malignant lesions and cancer, particularly in IBD where post-colonoscopy colorectal cancer rates are unacceptably high.
Publish Date 2022-03-30 15:20
Citation Halliday G, Porter RJ, Black CJ, Arends MJ, Din S. c-MET immunohistochemical expression in sporadic and inflammatory bowel disease associated lesions. World J Gastroenterol 2022; 28(13): 1338-1346
URL https://www.wjgnet.com/1007-9327/full/v28/i13/1338.htm
DOI https://dx.doi.org/10.3748/wjg.v28.i13.1338
Full Article (PDF) WJG-28-1338.pdf
Full Article (Word) WJG-28-1338.docx